News

Fierce Pharma13h
Scynexis says GSK on hook for $10M payment after phase 3 Brexafemme trial starts back up
A month after the FDA lifted its clinical hold on GSK’s vaginal yeast infection drug Brexafemme (ibrexafungerp), the ...
GlobalData on MSN13h
Scynexis resumes dosing in Phase III MARIO study after lengthy delay
Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a ...
Interesting Engineering on MSN13h
Next-gen drone flies with solid-state battery made for EVs for double range, payload
Factorial has announced the shipment of its first solid-state lithium-metal battery cells for drone use to Avidrone Aerospace.
rwjf.org9h
Research to Advance Racial and Indigenous Health Equity
E4A will fund Rapid Response Research grants at least to partially offset losses in federal funding for existing research, as well as New Research Support for action-oriented research to address ...